MPS Limited Board Approves Audited FY26 Results, Appoints KPMG as Internal Auditors
MPS Limited approved its Audited Financial Results for Q4 and FY ended March 31, 2026. The company decided not to recommend a final dividend for FY 2025-26. KPMG has been appointed as Internal Auditors for three years from FY 2026-27. Walker Chandiok & Co LLP has been re-appointed as Statutory Auditors for five years.
The appointment of new internal auditors and the re-appointment of statutory auditors are significant corporate governance events. The decision on dividend impacts shareholders directly. The approval of financial results is standard procedure. These factors collectively suggest a medium impact.
The announcement reports on financial results and auditor appointments. While the financial results are a routine disclosure, the non-recommendation of a dividend and the appointment of new internal auditors are notable events. The overall sentiment is neutral as it's a mix of routine and significant corporate actions without strong positive or negative financial indicators presented in the summary.
MPS Limited announced the outcome of its Board Meeting held on Friday, 15 May 2026. The Board approved the Audited Financial Results (Standalone and Consolidated) for the Fourth Quarter (Q4) and the Financial Year ended 31 March 2026. M/s. Walker Chandiok & Co LLP, the Statutory Auditors, issued an unmodified opinion on these results.
The Board decided not to recommend a final dividend for the financial year 2025-26, citing the deployment of cash flow towards the acquisition of Unbound Medicine, Inc. and the retention of capital to support future growth.
In a significant move, the Board approved the appointment of M/s. KPMG Assurance and Consulting Services LLP (“KPMG”) as the Internal Auditors for the Company and its Material Subsidiary for a term of three consecutive financial years, commencing from FY 2026-27 up to FY 2028-29. This appointment aims to ensure alignment in the internal audit framework across the Group.
Furthermore, M/s. Walker Chandiok & Co LLP were re-appointed as the Statutory Auditors of the Company and its Material Subsidiary for a second term of five consecutive years, starting from the conclusion of the upcoming 56th AGM until the conclusion of the 61st AGM in 2031, subject to shareholder approval. This re-appointment seeks to ensure consistency in audit methodology and reporting standards.
The Board Meeting commenced at 10:30 hours and concluded at 13:55 hours.
What to do with a filing like this
MPS Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by MPS Limited. Read the original for the full detail.